Healthcare
Live Price
Offline$25.18
+4.35% today
Window Change
+11.47%
Window
Nov 6, 2025 โ Jun 22, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 154 bars ยท Nov 6, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Evommune, Inc. (EVMN) is a Healthcare stock with a market cap of $310.00M and listed on NYSE. The stock last traded around $25.18 and up 11.5% across the available one-year price window (Nov 6, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +85.7%, EPS growth of +4.0%, a dividend yield of 0.0%. What stands out right now is revenue +85.7%, EPS +4.0%, free cash flow -31.6% with operating margin -623.6% and ROIC -39.0%. Valuation already assumes a fairly strong business story at price/sales 23.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines EVMN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
EVMN is 0.42 pts ahead over the shared 1Y window.
EVMN had 28.37 pts deeper max drawdown than SPY.
EVMN beat SPY in 1 of 2 calendar years shown and trailed in 1.
EVMN
+11.47%
Normalized return
SPY
+11.05%
S&P 500
Excess Return
+0.42 pts
Relative to SPY
EVMN Max Drawdown
-37.50%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for EVMN and SPY.
| Year | EVMN | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +30.27% | +6.71% | +23.56 pts | EVMN |
| 2025 | -13.40% | +11.19% | -24.59 pts | SPY |
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.